Balyasny Asset Management
FMS icon

Balyasny Asset Management’s Fresenius Medical Care FMS Stock Holding History

Balyasny Asset Management’s Portfolio FMS Stock Details FMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-70,000
Closed -$4.25M – 2885
2022
Q1 		$4.25M Buy
+70,000
New +$2.3M 0.01% 1019

Other funds holding FMS

Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Balyasny Asset Management's FMS Position: Q1 2026 in Review

Balyasny Asset Management sold out of Fresenius Medical Care (FMS) in Q1 2026, closing a stake of 75,530 shares — an estimated $1.8M sold.

Balyasny Asset Management first reported a position in FMS in Q1 2018 and held it in 11 quarters. The position peaked at $16M in Q1 2023. 218 funds tracked by Wall St. Rank hold FMS as of Q1 2026.

  • Balyasny Asset Management reported no remaining Fresenius Medical Care position as of Q1 2026 after selling out during the quarter.
  • Balyasny Asset Management sold 75,530 Fresenius Medical Care shares in Q1 2026, an estimated $1.8M.
  • Balyasny Asset Management first reported a position in Fresenius Medical Care in Q1 2018 and held it in 11 quarters.
  • Balyasny Asset Management's Fresenius Medical Care position peaked at $16M in Q1 2023.
  • 218 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.